Elena Gabriela Chiorean MD

Oncology•Seattle, WA

Gastrointestinal Cancer

Professor, Medicine, U of WA Sch of Med

Join to View Full Profile

825 Eastlake Ave EastLG-465Seattle, WA 98108
Phone+1 206-606-6324
Fax+1 206-606-1090

Education & Training

University of MinnesotaFellowship, Hematology and Medical Oncology, 1999 - 2002
Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 1995 - 1998
Iuliu Hatieganu University of Medicine and PharmacyClass of 1993

Certifications & Licensure

WA State Medical License 2012 - 2025
IN State Medical License 2004 - 2013
MN State Medical License 1999 - 2004
MI State Medical License 1997 - 2001
American Board of Internal Medicine Medical Oncology

Clinical Trials

Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer Start of enrollment: 2005 May 01
Terminated
Phase 2
Metabolomics-Based Detection of Colorectal Cancer Start of enrollment: 2007 Jul 01
Completed
Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas Start of enrollment: 2007 Sep 01
Terminated
Phase 2
Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors Start of enrollment: 2008 Jan 23
Completed
Phase 1
Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps Start of enrollment: 2009 Jan 01
Completed
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy Start of enrollment: 2011 Jan 18
Completed
Phase 2
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery Start of enrollment: 2010 Oct 15
Completed
Phase 2
Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer Start of enrollment: 2011 Jun 01
Withdrawn
Phase 2
Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma Start of enrollment: 2013 Apr 01
Completed
Phase 1
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer Start of enrollment: 2013 Apr 01
Terminated
Phase 2
Afatinib Dimaleate and Capecitabine in Treating Patients With Advanced Refractory Solid Tumors, Pancreatic Cancer or Biliary Cancer Start of enrollment: 2015 Nov 05
Completed
Phase 1
Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer Start of enrollment: 2019 May 10
COMPLETED
PHASE3
Join now to see all

Publications & Presentations

PubMed

Phase Ia/Ib Study of Afatinib with Capecitabine in Patients with Refractory Solid Tumors and Pancreaticobiliary Cancers.
Gentry G King, Kelsey K Baker, Andrew L Coveler, William P Harris, Stacey A Cohen
Cancers. 2025-05-30
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma.
Naomi Yamamoto, Stephanie Dobersch, Ian Loveless, Annie N Samraj, Gun Ho Jang
Clinical Cancer Research. 2025-02-17
A new dawn in cancer immunotherapy: the promise of mutant-specific vaccines.
Sheela Ruby Damle, Venu Gopal Pillarisetty, Rachael Ann Safyan, Elena Gabriela Chiorean
Translational Gastroenterology and Hepatology. 2025-01-01

Lectures

The Role of GLI-SOX2 Signaling Axis for Gemcitabine Resistance in Pancreatic Cancer
2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

New Study in JNCCN Supports Chemotherapy Option That Reduces Side Effects for People with Gastrointestinal CancersSeptember 5th, 2024

Elena Gabriela Chiorean MD

Dr. Chiorean is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Press Mentions

Viewing the full profile is available to verified healthcare professionals only.